4
Changes in Ownership
BIOMARIN PHARMACEUTICAL INC Filed Acc 0001048477-24-000114
EVP, Chief Financial Officer sold 5,000 shares at $75.19 ($375,950)
- EVP, Chief Financial Officer acquired 5,000 shares (option exercise)
- EVP, Chief Financial Officer acquired 300 shares (grant or award)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Mueller Brian · EVP, Chief Financial Officer
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-04-30 | Grant or award : show line 1 in the form 10b5-1 | +300 | $68.65 | $20,594 | 72,159 | D |
| 2024-05-30 | Exercise or conversion : show line 2 in the form 10b5-1 | +5,000 | $63.10 | $315,500 | 77,159 | D |
| 2024-05-30 | Sale : show line 3 in the form 10b5-1 | −5,000 | $75.19 | $375,950 | 72,159 | D |
| Open-market sales · 5,000 sh · avg $75.19 · $375,950 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-05-30 | Exercise or conversion : show line 4 in the form 10b5-1 Stock Option (Right to Buy Common Stock) | −5,000 | 0 | D |
Loading xslF345X05/wk-form4_1717194476.xml…